Atossa Therapeutics Inc ATOS:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 05/16/24 EDT
1.61UNCH (UNCH)
Volume
1,023,434
52 week range
0.62 - 2.31
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.61
  • 52 Week High2.31
  • 52 Week High Date04/05/24
  • 52 Week Low0.62
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap201.74M
  • Shares Out125.30M
  • 10 Day Average Volume1.50M
  • Dividend-
  • Dividend Yield-
  • Beta1.23
  • YTD % Change82.95

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close1.61
  • 52 Week High2.31
  • 52 Week High Date04/05/24
  • 52 Week Low0.62
  • 52 Week Low Date11/13/23
  • Market Cap201.74M
  • Shares Out125.30M
  • 10 Day Average Volume1.50M
  • Dividend-
  • Dividend Yield-
  • Beta1.23
  • YTD % Change82.95

RATIOS/PROFITABILITY

  • EPS (TTM)-0.24
  • P/E (TTM)-6.74
  • Fwd P/E (NTM)-6.26
  • EBITDA (TTM)-31.355M
  • ROE (TTM)-28.88%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Atossa Therapeutics Inc

 

Profile

MORE
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing medicines in areas of significant unmet medical need in oncology with a focus on using (Z)-endoxifen to prevent and treat breast cancer. Its lead drug candidate under development is oral (Z)-endoxifen, which it is developing for both the prevention and treatment of breast cancer. (Z)-endoxifen is the potent Selective Estrogen Receptor Modulator for estrogen receptor inhibition...
Steven Quay M.D., Ph.D.
Chairman of the Board, President, Chief Executive Officer
Heather Rees
Principal Financial and Accounting Officer
Address
107 Spring St
Seattle, WA
98104-1005
United States

Top Peers

SYMBOLLASTCHG%CHG
GALT
Galectin Therapeutics Inc
3.14+0.08+2.61%
KOD
Kodiak Sciences Inc
3.74UNCHUNCH
TRVI
Trevi Therapeutics Inc
2.84+0.07+2.71%
INO
Inovio Pharmaceuticals Inc
12.79-0.28-2.14%
DRTS
Alpha Tau Medical Ltd
2.67+0.02+0.75%